Related Experiment Video
Updated: May 16, 2026

Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes
Published on: March 12, 2013
c-Jun N-terminal kinase activation contributes to reduced connexin43 and development of atrial arrhythmias
Jiajie Yan1, Wei Kong, Qiang Zhang
1Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Insights
c-Jun N-terminal kinase (JNK) activation contributes to reduced connexin43 (Cx43) levels, promoting atrial fibrillation (AF). Targeting JNK may offer a new therapeutic strategy for AF prevention and treatment.
Area of Science:
- Cardiovascular Research
- Molecular Biology
- Electrophysiology
Background:
- c-Jun N-terminal kinase (JNK) activation is linked to cardiovascular diseases and aging, conditions associated with increased atrial fibrillation (AF) risk.
- The specific role of JNK in the development of AF, particularly its impact on gap junction proteins, remains largely unknown.
Purpose of the Study:
- To investigate the contribution of JNK to the remodeling of gap junction connexin43 (Cx43).
- To determine the role of JNK in the development of atrial fibrillation (AF).
Main Methods:
- Experiments were conducted on young and aged rabbit atria and HL-1 atrial cells.
- Assays included pacing-induced arrhythmias, optical mapping, biochemical analysis, JNK activation/inhibition, and Cx43 manipulation.
Main Results:
- Aged atria exhibited increased arrhythmias, slower conduction velocity, elevated JNK activation, and reduced Cx43 compared to young atria.
- JNK activation mimicked aged atrial phenotypes, causing Cx43 reduction, slower conduction, and irregular activity, effects reversed by JNK inhibition or Cx43 overexpression.
Conclusions:
- JNK activation directly contributes to Cx43 reduction, a key mechanism promoting AF development.
- Modulating JNK activity presents a potential novel therapeutic avenue for preventing and treating AF.
Aims:
c-Jun N-terminal kinase (JNK) activation is implicated in cardiovascular diseases and ageing, which are linked to enhanced propensity to atrial fibrillation (AF). However, the contribution of JNK to AF remains unknown. Thus, we assessed the role of JNK in remodelling of gap junction connexin43 (Cx43) and development of AF.
Methods And Results:
AF induction, optical mapping, and biochemical assays were performed in young and aged New Zealand white rabbit left atria (LA) and cultured HL-1 atrial cells. In aged rabbit LA, pacing-induced atrial arrhythmias were dramatically increased and conduction velocity (CV) was significantly slower compared with young controls. Aged rabbit LA contained 120% more activated JNK and 54% less Cx43 than young LA. Young rabbits treated with JNK activator anisomycin also exhibited increased pacing-induced atrial arrhythmias and reduced Cx43 (by 34%), similar to that found in aged LA. In HL-1 cell cultures, anisomycin treatment for 16 h led to 42% reduction in Cx43, 24% reduction in CV, and an increased incidence of irregular rapid spontaneous activities. These effects were prevented by a specific JNK inhibitor, SP600125. Moreover, a 63% reduction in Cx43 after anisomycin treatment for 24 h led to further slowed CV (by 41%) along with dramatically increased irregular rapid spontaneous activity and highly discontinuous conduction. These JNK-induced functional abnormalities were completely reversed by overexpressed exogenous wild-type Cx43, but not by inactive Cx43.
Conclusion:
JNK activation contributes to Cx43 reductions that promote development of AF. Modulation of JNK may be a potential novel therapeutic approach to prevent and treat AF.
More Related Videos
Related Concept Videos
Mechanism of Cardiac Arrhythmias
MAPK Signaling Cascades
Gap Junctions
Gap Junctions
cAMP-dependent Protein Kinase Pathways
The JAK-STAT Signaling Pathway

